Kahn Swick & Foti & PROCEPT BioRobotics
2 shared events · Importance 3 · Last updated Sep 12, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Kahn Swick & Foti: One of the plaintiff law firms soliciting investors for the class action. It benefits from potential fees if the case succeeds.
PROCEPT BioRobotics: Central defendant in the securities fraud class action. The company's stock plummeted over 48% from August 2025 to February 2026 due to revelations of undisclosed discounting and inventory glut, and it now faces significant legal and financial exposure.
Jul 24, 2026 · 303 articles
Regulatory
Kahn Swick & Foti: Filed a securities class action against PROCEPT and is urging investors with substantial losses to seek lead plaintiff appointment.
PROCEPT BioRobotics: The central defendant in the securities fraud class action, facing allegations of misleading investors about handpiece sales and inventory practices. The litigation and associated stock declines of over 48% from August 2025 to February 2026 pose significant financial and reputational risks.
Aug 03, 2026 · 140 articles
80
Kahn Swick & Foti filed securities class action PROCEPT BioRoboticsPROCEPT BioRobotics...
45
Kahn Swick & Foti notified investors PROCEPT BioRoboticsPROCEPT BioRobotics...
ERGEN INTELLIGENCE
Explore this relationship live
Track how Kahn Swick & Foti and PROCEPT BioRobotics interact across events, view sentiment trends, and discover connected entities.
Open Dashboard